Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🇳🇿 NZ Market
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Food, Beverage & Tobacco
Any
Automobiles
Banks
Capital Goods
Commercial Services
Consumer Durables
Consumer Services
Diversified Financials
Energy
Consumer Retailing
Food, Beverage & Tobacco
Healthcare
Household
Insurance
Materials
Media
Pharmaceuticals & Biotech
Real Estate
Retail
Semiconductors
Software
Tech
Telecom
Transportation
Utilities
Create a narrative
Community
/
New Zealand
/
Food, Beverage & Tobacco
Food, Beverage & Tobacco Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Food, Beverage & Tobacco Investing Ideas
All companies
Popular
Undervalued
Overvalued
a2 Milk
AN
AnalystConsensusTarget
Consensus Narrative from 8 Analysts
Supply Constraints And Capital Costs Will Weigh On Earnings, But New Products May Improve Future Prospects
Key Takeaways The company's expansion and reliance on costly air freight impact margins and could pressure revenue if investment returns disappoint. Challenges in key markets, including declining ANZ performance and competition in China, threaten growth amidst costly product launches.
View narrative
NZ$8.86
FV
10.0% overvalued
intrinsic discount
5.44%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
18
users have followed this narrative
Updated
narrative
Synlait Milk
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Advanced Nutrition And Foodservice Will Face Risks And Upside
Key Takeaways Reliance on Advanced Nutrition sales may lead to slower future growth due to unsustainable restocking and new product launches. Challenges like high fat pricing and unsecured milk supply could pressure margins and impact future profitability and cash flow.
View narrative
NZ$0.51
FV
38.5% overvalued
intrinsic discount
4.80%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
9 days ago
author updated this narrative
New Zealand King Salmon Investments
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Blue Endeavour Project Will Expand Aquaculture Production
Key Takeaways Blue Endeavour's government-backed expansion and strategic market development, especially in China, are poised to drive significant future growth and revenue increases. Investments in sustainability and brand partnerships aim to enhance operational efficiency, reduce costs, and boost demand, positively impacting margins and earnings.
View narrative
NZ$0.27
FV
24.1% undervalued
intrinsic discount
4.77%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
3 days ago
author updated this narrative
Scales
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Acquisitions And Expansions Will Boost Global Proteins And Horticulture Operations In Future
Key Takeaways Strategic investments in premium apple varieties and logistics are expected to boost revenues and margins in Horticulture and Logistics segments over the coming years. Expansion and profitability in Global Proteins, including Meateor Australia and Esro Petfood, will enhance earnings and contribute to overall EBITDA growth by 2025.
View narrative
NZ$5.20
FV
8.7% undervalued
intrinsic discount
6.49%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
3 days ago
author updated this narrative
Value any company in seconds
Popular companies